ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

304
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
bearishSamsung C&T
24 Dec 2017 21:58

Samsung Governance Reform - Why Local Institutions Turning Away from C&T?

It certainly seems that this is a very rare event. Honestly, I don't recall anything like this, that one of Korea's top regulation agencies...

Logo
175 Views
Share
28 Nov 2017 16:52

Drugs Evolving Into 'Biological Software' to Boost Moribund Pharma Sector?

The global pharma and biotech sector has underperformed by about four points this year, and five over three years – the divergence with other...

Logo
223 Views
Share
06 Nov 2017 00:54

Samsung Electronics Common-Pref Spread - Data & Situational Study

Let's do one interesting study here. In the last month (Oct 10-Nov 3), Samsung Electronics Pref Shares (005935 KS) ranked fifth in the local...

Logo
317 Views
Share
bullishSamsung C&T
04 Nov 2017 22:10

Samsung Restructuring Update - New Scenario Attracts Local Institutions

Last week, we heard a couple of major news from Samsung Electronics Co Ltd (005930 KS). First, SamE made headlines with its new 3-year shareholder...

Logo
484 Views
Share
bullishSK Telecom
09 Oct 2017 03:05

SK Group Restructuring - Local Institutions Are Already Making A Move

We are now seeing a very interesting move from Korea's local institutions on those SK Group restructuring stocks. Last week, to be specific from...

Logo
349 Views
Share
x